Monoclonal antibodies to transforming growth factor-beta and methods of use
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 30, 1998
Issued Date -
N/A
app pub date -
May 4, 1995
filing date -
Dec 22, 1988
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Monoclonal antibodies to transforming growth factor beta (TGF-B) are prepared from hybrid cell lines by immunizing with TGF-B2. The antibodies may be of any isotype and may be of any mammalian origin such as murine or human origin. Therapeutic applications utilizing the TGF-B monoclonal antibody are also disclosed.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully